Another study, conducted by Jing et al., conducted a retrospective analysis of 165 cases of advanced NSCLC undergoing platinum-based chemotherapy and bevacizumab treatment, utilizing IHC to differentiate between MTAP-low and MTAP-high patients. Here, MTAP is linked to non-small cell lung carcinoma.